Specialty Pharmacy

Press enter to search
Close search
Open Menu

Specialty Pharmacy

Walmart expanding prescription drug cost savings via Capital Rx

Walmart will use Capital Rx's Clearinghouse Model to keep drug prices at bay for specialty and mail-order prescriptions.

The words approved in caps and red letters.

Valeo Pharma receives FDA OK for ethacrynate sodium

Valeo's ethacrynate sodium will be launched this summer.

A document being signed.

Akorn said it will continue to operate as usual throughout the duration of the Chapter 11 and sale process, including meeting its contractual obligations and making payments to vendors.

Pill bottles of different sizes with pills.

MaxorPlus clients can choose Amber Pharmacy’s service model for members with organ transplant medication needs.

A hand holding a prescription box.

AmerisourceBergen is providing a unified commercialization approach for Qinlock, a treatment for patients with a rare form of cancer.

A female pharmacist with a male patient at the counter.

A Surescripts survey finds that nearly two-thirds of specialty pharmacists report spending more than 15 minutes on the phone to fill one prescription.

AllianceRx Walgreens Prime will distribute Lundbeck's Vyepti, an intravenous preventive migraine treatment.

Colored pills on the face on money.

IQVIA reports that global use of medicine has increased at a 3% compound annual growth rate since 2014, slowing from a 4% rate from 2009–2014.

A nasal spray.

Glenmark and Hikma will commercialize a fixed-dose combination nasal spray for seasonal allergic rhinitis.

The Remunity system to treat pulmonary arterial hypertension is expected to be available by July for specialty pharmacies.

Walgreens has earned the first enterprise-wide URAC Specialty Pharmacy accreditation for its network of more than 300 community specialty pharmacies.

A handshake between two people.

Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer.

Diplomat headquarters.

Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment

Diplomat is retaining a portion of the Envoy Health Management operations that specialize in digital therapeutics and pharmaceutical services.

Show More